Jane A. Gross - 17 Mar 2025 Form 4 Insider Report for aTYR PHARMA INC (ATYR)

Role
Director
Signature
/s/ Nancy E. Denyes, as Attorney-in-Fact
Issuer symbol
ATYR
Transactions as of
17 Mar 2025
Transactions value $
$15,000
Form type
4
Filing time
17 Mar 2025, 19:07:42 UTC
Previous filing
23 May 2024
Next filing
02 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATYR Common Stock Purchase $15,000 +3,750 +62% $4 9,750 17 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.